Autologous stromal vascular fraction(Hayandra Peduli Foundation)

N/A

Report date: 2023/06/30 20:00:34

Base Information

Drug NameAutologous stromal vascular fraction(Hayandra Peduli Foundation)
Drug Alias NameAutologous stromal vascular fraction (SVF)(Hayandra Peduli Foundation)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndonesia
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHayandra Peduli Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHayandra Peduli Foundation
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A
Related LinksN/A